Italia markets open in 5 hours 4 minutes

TEVA Dec 2024 18.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,10000,0000 (0,00%)
In data: 10:19AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,1000
Aperto1,1000
Denaro1,2400
Domanda1,5300
Prezzo d'esercizio18,00
Scadenza2024-12-20
Min-Max giorno1,1000 - 1,1000
Contratto - Min-MaxN/D
Volume5
Open Interest10,81k
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.